What Researchers Did
Researchers reported a case of a 41-year-old woman who developed late-onset vascular complications following hyaluronic acid filler injection.
What They Found
The patient experienced delayed vascular complications 28 hours post-injection, which did not respond to low-dose hyaluronidase. Full recovery was achieved after escalation to high-dose hyaluronidase (6000 IU) combined with platelet-rich fibrin and hyperbaric oxygen therapy.
What This Means for Canadian Patients
This case suggests that aggressive, multimodal management, including high-dose hyaluronidase, may be effective for delayed vascular complications from hyaluronic acid fillers. Patients experiencing such complications should seek prompt medical attention for potential advanced treatment options.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
As a single case report, the findings may not be generalizable to a broader patient population.